COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 456
[35] De Brabander M, et al. Microtubule dynamics and
microtubule-dependent intracellular transport. Int J Biochem.
1993;25(2):141-148.
[36] Zempel H, Mandelkow E. Lost after translation: missorting of
Tau protein and consequences for Alzheimer disease. Trends
Neurosci. 2014;37(12):721-732.
[37] Abou-Donia MB, et al. Autoantibodies to nervous
system-specific proteins are elevated in sera of flight crew
members: biomarkers for nervous system injury. J Toxicol Environ
Health A. 2013;76(6):363-380.
[38] Eng LF, Ghirnikar RS, Lee YL. Glial fibrillary acidic protein:
GFAP-thirty-one years (1969-2000). Neurochem Res.
2000;25(9-10):1439-1451.
[39] Messing A, Brenner M. GFAP at 50. ASN Neuro.
2020;12:1759091420949680.
[40] Ghatak NR. Occurrence of oligodendrocytes within astrocytes
in demyelinating lesions. J Neuropathol Exp Neurol.
1992;51(1):40-46.
[41] Nuriya M, Yasui M. Glial cells and their function in the adult
brain: a journey through the history of their ablation. Front Cell
Neurosci. 2013;7:38.
[42] Pekny M, Wilhelmsson U, Pekna M. The dual role of astrocyte
activation and reactive gliosis. Neurosci Lett. 2014;565:30-38.
[43] Barthel PC, et al. Immunoreactivity to astrocytes in different
forms of dementia: High prevalence of autoantibodies to GFAP.
European Journal of Medical Research. 2023;28:1-15.
[44] Shan F, Zhu F, Li H, Shi L, Li G, Tang X. Updates on the Clinical
Significance of Anti-GFAP Antibodies in the Central Nervous
System. Front Immunol. 2021;12:729227.
456
